Target intelligence / Profile preview

Propionic acid (Propionate) (PPA)

Target
PPA
Molecular classification
Short-chain fatty acid, Metabolite, Ligand, Carboxylic acid
01

Overview

Propionate, or propionic acid, is a three-carbon short-chain fatty acid (SCFA) primarily produced by the intestinal microbiota during the fermentation of dietary fibers. It serves as a vital signaling molecule that bridges the gut microbiome and host physiology by activating specific G protein-coupled receptors, namely Free Fatty Acid Receptor 2 (FFAR2/GPR43) and Free Fatty Acid Receptor 3 (FFAR3/GPR41). Propionate is involved in maintaining energy homeostasis by acting as a precursor for hepatic gluconeogenesis and regulating appetite through the stimulation of gut hormones like GLP-1 and PYY. It also exhibits potent anti-inflammatory effects by modulating immune cell activity and inhibiting histone deacetylases (HDACs). While beneficial at physiological levels, abnormal propionate content is associated with various pathologies; for instance, low levels are linked to obesity and inflammatory bowel disease, while excessive accumulation is a hallmark of the genetic disorder propionic acidemia, which leads to neurotoxicity and metabolic acidosis. Therapeutic strategies include the use of prebiotics like inulin to boost endogenous production and pharmacological agents like L-carnitine or antibiotics to manage toxic levels in metabolic disorders.

Other names
Propanoic acidPropionateC3Methylacetic acidEthanecarboxylic acid
02

Mechanism of action

Activation of G protein-coupled receptors (FFAR2/GPR43 and FFAR3/GPR41), inhibition of histone deacetylases (HDACs), and serving as a substrate for hepatic gluconeogenesis.

03

Biological functions

Energy metabolismSignal transductionImmune responseAppetite regulationHistone deacetylase inhibition
04

Disease associations

ObesityType 2 diabetesInflammatory bowel diseasePropionic acidemiaCardiovascular diseaseColorectal cancer
05

Safety considerations

Neurotoxicity at high concentrationsMetabolic acidosisMitochondrial dysfunctionHyperammonemia
06

Interacting drugs

Inulin

4 more in the full profile.

07

Biomarkers

Fecal propionate concentrationSerum propionate levelsPropionyl-CoA levelsMethylcitrate

Beyond the preview

Go deeper on Propionic acid (Propionate) (PPA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Propionic acid (Propionate) (PPA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call